SomaLogic (NASDAQ:SLGC) Rating Lowered to Sell at Zacks Inve

SomaLogic (NASDAQ:SLGC – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK. […]

Related Keywords

New York , United States , Thomson Reuter , Stifel Nicolaus , Raymond James Financial Services Advisors Inc , York State Common Retirement Fund , Zacks Investment Research , Commonwealth Equity Services , Cm Life Sciences Ii Inc , Somalogic Inc , Td Asset Management Inc , Financial Services Group Inc , Get Rating , Logic Inc , Equity Services , James Financial Services Advisors , Services Group , Somalogic , Nasdaq Slgc , Slgc , Business Service , Downgrade ,